Guo Qingkui, Zheng Min, Zhu Chen, Wu Bin
Department of Thoracic Surgery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Biomol Biomed. 2024 Dec 11;25(1):155-164. doi: 10.17305/bb.2024.10944.
Circular RNA (circRNA) has been widely studied as a competitive endogenous RNA targeting microRNA (miRNA)/messenger RNA to regulate cancer progression. However, the regulatory mechanism of circ_0023179 in non-small cell lung cancer (NSCLC) remains unclear. The expression levels of circ_0023179, miR-615-5p and Cadherin 3 (CDH3) in NSCLC were detected using quantitative real-time polymerase chain reaction. The stability of circ_0023179 was verified using ribonuclease R enzyme, actinomycin D and agarose gel electrophoresis. Colony formation and thymidine analog 5-ethynyl-2'-deoxyuridine assays were performed to examine proliferation changes in NSCLC cells. Western blot was used to assess the levels of CDH3 and epithelial-mesenchymal transition (EMT)-related marker proteins to evaluate EMT. Dual-luciferase reporter, RNA immunoprecipitation (RIP), and RNA pull-down assays were performed to explore the potential mechanisms of circ_0023179 in regulating NSCLC progression. Finally, the effects of circ_0023179 on NSCLC tumour growth in vivo were explored using a nude mouse subcutaneous tumour model. The results showed that the expression of circ_0023179 was remarkably higher in NSCLC tissues and cells, and it had a significant effect on NSCLC cell proliferation. Additionally, the knockdown of circ_0023179 significantly inhibited tumour growth in NSCLC mice. Mechanistically, circ_0023179 alleviated its inhibition of downstream CDH3 through the sponge-like adsorption of miR-615-5p. The downregulation of miR-615-5p and the upregulation of CDH3 mitigated the inhibitory effect of silencing circ_0023179 on NSCLC cell proliferation. In conclusion, silencing circ_0023179 inhibited NSCLC cell proliferation by targeting the miR-615-5p/CDH3 axis involved in NSCLC progression.
环状RNA(circRNA)作为一种竞争性内源性RNA,通过靶向微小RNA(miRNA)/信使RNA来调节癌症进展,已得到广泛研究。然而,circ_0023179在非小细胞肺癌(NSCLC)中的调控机制仍不清楚。采用定量实时聚合酶链反应检测NSCLC中circ_0023179、miR-615-5p和钙黏蛋白3(CDH3)的表达水平。使用核糖核酸酶R酶、放线菌素D和琼脂糖凝胶电泳验证circ_0023179的稳定性。进行集落形成和胸腺嘧啶类似物5-乙炔基-2'-脱氧尿苷试验,以检测NSCLC细胞的增殖变化。采用蛋白质免疫印迹法评估CDH3水平和上皮-间质转化(EMT)相关标志物蛋白,以评估EMT。进行双荧光素酶报告基因、RNA免疫沉淀(RIP)和RNA下拉试验,以探究circ_0023179调控NSCLC进展的潜在机制。最后,利用裸鼠皮下肿瘤模型探究circ_0023179对NSCLC体内肿瘤生长的影响。结果显示,circ_0023179在NSCLC组织和细胞中的表达显著更高,且对NSCLC细胞增殖有显著影响。此外,敲低circ_0023179可显著抑制NSCLC小鼠的肿瘤生长。机制上,circ_0023179通过海绵样吸附miR-615-5p减轻了其对下游CDH3的抑制作用。miR-615-5p的下调和CDH3的上调减轻了沉默circ_0023179对NSCLC细胞增殖的抑制作用。总之,沉默circ_0023179通过靶向参与NSCLC进展的miR-615-5p/CDH3轴抑制NSCLC细胞增殖。